Propensity score-matched evaluation of palliative transurethral resection and holmium laser enucleation of the prostate for bladder outlet obstruction in patients with prostate cancer

被引:3
作者
Tamalunas, Alexander [1 ]
Keller, Patrick [1 ]
Schott, Melanie [1 ]
Stadelmeier, Leo Federico [1 ]
Kidess, Marc [1 ]
Atzler, Michael [1 ]
Ebner, Benedikt [1 ]
Hennenberg, Martin [1 ]
Stief, Christian G. [1 ]
Magistro, Giuseppe [2 ]
机构
[1] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Urol, Munich, Germany
[2] Asklepios Westklinikum Hamburg, Dept Urol, Hamburg, Germany
关键词
MANAGEMENT; COMPLICATIONS; EFFICACY; IMPACT; LIFE;
D O I
10.1038/s41391-024-00831-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background While transurethral resection of the prostate (TURP) is the standard-of-care, Holmium laser enucleation of the prostate (HoLEP) is widely accepted as a size-independent method for surgical treatment of patients with lower urinary tract symptoms (LUTS) secondary to bladder outlet obstruction (BOO). However, in an ageing society an increasing number of patients presents with BOO due to locally advanced prostate cancer. There is currently no guidelines recommendation as to the enucleation or resection technique. Therefore, we compared intraoperative performance, postoperative outcomes, and safety for palliative (p)TURP and (p)HoLEP.Methods We conducted a retrospective, propensity score-matched analysis of 1373 and 2705 men who underwent TURP or HoLEP for LUTS/BOO between 2014 and 2021, respectively. Patients were matched for age, prostate size and preoperative international prostate symptom score (IPSS). Patients were stratified by technique and groups were compared for perioperative parameters, safety, and functional outcomes.Results While postoperative symptoms and urodynamic parameters improved irrespective of technique, we report significantly increased resection and enucleation times for palliative indication. For corresponding efficiency parameters, we observed a two-fold higher surgical performance (g/min) for both techniques in patients without prostate cancer. While adverse events were comparable between groups, we found a two-fold higher hemoglobin drop in palliative patients.Conclusions Currently, there is no standard-of-care for patients with BOO and locally advanced prostate cancer. Our data show that both TURP and HoLEP offer adequate symptom improvement and comparable safety profiles. While HoLEP is feasible even in larger prostates, both procedures become more difficult in patients with prostate cancer. Taken together, this study covers an important gap in current literature, helping urological surgeons to make evidence-based decisions for the benefit of their patients.
引用
收藏
页码:153 / 159
页数:7
相关论文
共 33 条
[1]   Holmium Laser Enucleation of the Prostate Is Safe in Patients with Prostate Cancer and Lower Urinary Tract Symptoms-A Retrospective Feasibility Study [J].
Becker, Andreas ;
Placke, Anne ;
Kluth, Luis ;
Schwarz, Rudolf ;
Isbarn, Hendrik ;
Chun, Felix ;
Heuer, Roman ;
Schlomm, Thorsten ;
Seiler, Daniel ;
Engel, Oliver ;
Fisch, Margit ;
Graefen, Markus ;
Ahyai, Sascha A. .
JOURNAL OF ENDOUROLOGY, 2014, 28 (03) :335-341
[2]  
Cornu J.N., 2023, EAU ANN C MIL MARCH
[3]   Palliative transurethral prostate resection for bladder outlet obstruction in patients with locally advanced prostate cancer [J].
Crain, DS ;
Amling, CL ;
Kane, CJ .
JOURNAL OF UROLOGY, 2004, 171 (02) :668-671
[4]  
Das Akhil K, 2020, Can J Urol, V27, P44
[5]   Transurethral Laser Surgery for Benign Prostate Hyperplasia in Octogenarians: Safety and Outcomes [J].
Elshal, Ahmed M. ;
Elmansy, Hazem M. ;
Elhilali, Mostafa M. .
UROLOGY, 2013, 81 (03) :634-639
[6]   Supportive care, pain management, and quality of life in advanced prostate cancer [J].
Esper, P ;
Redman, BG .
UROLOGIC CLINICS OF NORTH AMERICA, 1999, 26 (02) :375-+
[7]   Does the prostatic vascular system contribute to the development of benign prostatic hyperplasia? [J].
Ghafar M.A. ;
Puchner P.J. ;
Anastasiadis A.G. ;
Cabelin M.A. ;
Buttyan R. .
Current Urology Reports, 2002, 3 (4) :292-296
[8]   Holmium laser resection of the prostate: Preliminary results of a new method for the treatment of benign prostatic hyperplasia [J].
Gilling, P ;
Cass, CB ;
Cresswell, MD ;
Fraundorfer, MR .
UROLOGY, 1996, 47 (01) :48-51
[9]   From BPH to male LUTS: a 20-year journey of the EAU guidelines [J].
Gravas, Stavros ;
Malde, Sachin ;
Cornu, Jean-Nicolas ;
Gacci, Mauro ;
Gratzke, Christian ;
Herrmann, Thomas R. W. ;
Karavitakis, Markos ;
Mamoulakis, Charalampos ;
Rieken, Malte ;
Sakalis, Vasileios I. ;
Schouten, Natasha ;
Smith, Emma J. ;
Speakman, Mark J. ;
Tikkinen, Kari A. O. ;
Alivizatos, Gerasimos ;
Bach, Thorsten ;
Bachmann, Alexander ;
Descazeaud, Aurelian ;
Desgrandchamps, Francois ;
Drake, Marcus ;
Emberton, Mark ;
Kyriazis, Iason ;
Madersbacher, Stephan ;
Michel, Martin C. ;
N'Dow, James ;
Perachino, Massimo ;
Plass, Karin ;
Rioja Sanz, Carlos ;
Umbach, Roland ;
de Wildt, Michel ;
Oelke, Matthias ;
de la Rosette, Jean J. M. C. H. .
PROSTATE CANCER AND PROSTATIC DISEASES, 2024, 27 (01) :48-53
[10]   Two Decades of Active Surveillance for Prostate Cancer in a Single-Center Cohort: Favorable Outcomes after Transurethral Resection of the Prostate [J].
Hagmann, Sarah ;
Ramakrishnan, Venkat ;
Tamalunas, Alexander ;
Hofmann, Marc ;
Vandenhirtz, Moritz ;
Vollmer, Silvan ;
Hug, Jsmea ;
Niggli, Philipp ;
Nocito, Antonio ;
Kubik-Huch, Rahel A. ;
Lehmann, Kurt ;
Hefermehl, Lukas John .
CANCERS, 2022, 14 (02)